Breaking News Bar
updated: 9/3/2014 5:12 PM

Google's health startup forges venture with AbbVie

hello
Success - Article sent! close
  • North Chicago-based AbbVie Inc., the drugmaker spun off from Abbott Laboratories last year, and Google Inc.'s Calico will spend as much as $1.5 billion to tackle age-related diseases, including cancer and neurodegenerative disorders. See here is AbbVie's signature drug Humira.

      North Chicago-based AbbVie Inc., the drugmaker spun off from Abbott Laboratories last year, and Google Inc.'s Calico will spend as much as $1.5 billion to tackle age-related diseases, including cancer and neurodegenerative disorders. See here is AbbVie's signature drug Humira.
    ASSOCIATED PRESS

 
Associated Press

SAN FRANCISCO -- Google's ambitious health startup is teaming up with North Chicago-based biotechnology drugmaker AbbVie in a $500 million joint venture that will try to develop new ways to treat cancer and other diseases such as Alzheimer's.

The alliance announced Wednesday calls for Google Inc. and AbbVie Inc. to each invest $250 million in the project. An additional $1 billion may be poured into the project. The two companies will split all expenses and any profits generated by the venture.

Calico, a company hatched by Google last year, will manage a team of scientists who will work at a research-and-development lab in the San Francisco Bay Area. The precise location and size of the new lab hasn't been determined.

AbbVie, a spin-off from Abbott Laboratories, will oversee the marketing of the drugs. Abbvie already has been working on drugs to fight Parkinson's disease, Crohn's and other ailments.

AbbVie's "broad R&D experience and capabilities will complement Calico's biotechnology expertise and innovative scientific approaches," Michael Severino, AbbVie's chief scientific officer, said in the statement.

Google set up Calico as separate business last year to pursue medical breakthroughs that would enable people to live longer. Toward that end, Calico is doing extensive research to get a better understanding about how the human body ages and working on technology that could cure cancer.

Calico is run by Arthur Levinson, a former CEO of biotech pioneer Genentech and a former member of Google's board. He is also chairman of Apple Inc., which is expected to provide further details to help people manage their health next week when the company unveils its latest iPhone. The expansion into health also could include a new Apple device that could be worn on a person's wrist.

In announcing Calico's creation, Google CEO Larry Page said in a blog post that the company hoped to improve "millions of lives" with "longer term, moonshot thinking around health care and biotechnology."

AbbVie Inc. shares slipped 8 cents to $54.99 in afternoon trading Wednesday, while Google shares gained 25 cents to $577.58.

Share this page
Comments ()
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the X in the upper right corner of the comment box. To find our more, read our FAQ.